Reports + Research

Ionis Makes Second Drug Development Deal with Janssen Biotech

Ionis Pharmaceuticals licenses second orally delivered antisense drug to Janssen. The drug is designed to act against an undisclosed target in the gastrointestinal tract for the treatment of a GI autoimmune disease. Under the deal, Ionis could receive nearly $800 million in regulatory, sales milestone payments, and license fees.

MedCrypt Aims to Protect Medical Devices from Cyber Attacks

As more health care data becomes contained on medical devices, it is increasingly a target for hackers and cyber attacks. A Q&A with MedCrypt describes how this San Diego startup is using ATM security technologies to protect medical data.

Salk Institute’s New Chairman

Salk Institute trustees elected Daniel C. Lewis as board chairman. Lewis is the former president of the management-consulting firm Booz Allen Hamilton. Lewis will be leading the charge on increasing private philanthropy to the institute to support faculty recruitment and retention.

Biolinq Secures $10M Series A for Wireless Biosensor Patch for Diabetes

The round was led by M Ventures in collaboration with Hikma Ventures and joined by Grey Sky Venture Partners, Three Leaf Ventures, LifeSci Venture Partners, and diabetes-focused individual investors. Biolinq is developing a minimally invasive, skin-applied biosensor to continuously monitor blood glucose.

Read + Listen

POW! Podcast of the Week

Crinetics’ founder and CEO, Scott Struthers, Ph.D., spoke with J D Faccinetti for a podcast for Pituitary World News, looking into the world of new drug discovery and development for acromegaly and other endocrine diseases.

BOW! Book of the Week

Did you know one in three people in the United States will develop type 2 diabetes in their lifetime? Here’s a book about dealing with disease: Cheating Destiny.

Events

It’s Happening Here

December 5–7Learn about the next generation of cancer immunotherapies at imPACT Immunotherapy conference at Hilton Bayfront from December 5–7.

December 11
San Diego biotech’s serial entrepreneurs and leaders come together on December 11 to gaze into the future. Xconomy’s San Diego Life Sciences 2022 will take place Monday, December 11, at Alexandria on Torrey Pines Mesa.